🔗 Permalink

Inventor profile of:

Wayne A. Marasco

City:

Wellesley, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-06-18

Top Assignees for applications by Wayne A. Marasco

The entities that hold a legal rights for patent applications filed by inventor Marasco Wayne A.:

Dana-Farber-Cancer Institute, Inc. 34 Boston, MA United States
Burnham Institute for Medical Research 2 La Jolla, CA United States
DANA-FARBER CANCER INSTITUTE, INC. 2 BROOKLINE, MA United States
Dana-Farber Cancer Institute 2 Boston, MA United States
Brigham and Women's Hospital 1 Boston, MA United States
The Brigham and Women's Hospital 1 Boston, MA United States
BURNHAM INSTITUTE FOR MEDICAL RESEARCH 1 92037, CA United States

Recent patent applications by Marasco Wayne A.

Wayne A. Marasco from Wellesley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18

US20260167702A1

Chemistry; metallurgy

HUMAN BROADLY CROSSREACTIVE INFLUENZA MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

#2 | 2026-04-30

US20260116995A1

Chemistry; metallurgy

ANTIBODIES AGAINST MUC1 AND METHODS OF USE THEREOF

#3 | 2026-02-26

US20260053909A1

Human necessities

GENOMIC VARIANTS IN IG GENE REGIONS AND USES OF SAME

#4 | 2025-11-06

US20250339521A1

Human necessities

HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF

#5 | 2025-09-25

US20250296975A1

Chemistry; metallurgy

ENGINEERED CELLS, T CELL IMMUNE MODULATING ANTIBODIES AND METHODS FOR USING THE SAME

#6 | 2025-08-14

US20250255902A1

Human necessities

GENETICALLY ENGINEERED B CELLS AND METHODS OF USE THEREOF

#7 | 2025-07-31

US20250243259A1

Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

#8 | 2025-02-27

US20250066481A1

Chemistry; metallurgy

FC VARIANT COMPOSITIONS AND METHODS OF USE THEREOF

#9 | 2025-01-09

US20250011462A1

Chemistry; metallurgy

METHOD OF TREATING A TUMOR EXPRESSING CARBONIC ANHYDRASE IX (G250) BY ADMINISTERING A G250-SPECIFIC CHIMERIC ANTIGEN RECEPTOR

#10 | 2024-12-12

US20240409617A1

Chemistry; metallurgy

MULTISPECIFIC CORONAVIRUS ANTIBODIES

#11 | 2024-10-10

US20240336694A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR AUGMENTING ANTIBODY MEDIATED RECEPTOR SIGNALING

#12 | 2024-04-11

US20240115697A1

Human necessities

HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF

#13 | 2023-04-27

US20230127123A1

Chemistry; metallurgy

ANTIBODIES AGAINST PD-L1 AND METHODS OF USE THEREOF

#14 | 2022-09-15

US20220289863A1

Chemistry; metallurgy

ANTIBODIES AGAINST MUC1 AND METHODS OF USE THEREOF

#15 | 2022-09-01

US20220275088A1

Chemistry; metallurgy

ANTIBODIES AGAINST PD-1 AND METHODS OF USE THEREOF

#16 | 2022-08-11

US20220249640A1

Human necessities

ANTIBODIES AGAINST PD-1 AND METHODS OF USE THEREOF

#17 | 2022-07-07

US20220213206A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR AUGMENTING ANTIBODY MEDIATED RECEPTOR SIGNALING

#18 | 2022-05-05

US20220135655A1

Chemistry; metallurgy

IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES

#19 | 2022-03-31

US20220098314A1

Chemistry; metallurgy

GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) ANTIBODIES AND METHODS OF USE THEREOF

#20 | 2022-03-24

US20220088174A1

Human necessities

GENOMIC VARIANTS IN IG GENE REGIONS AND USES OF SAME

#21 | 2022-02-24

US20220054624A1

Human necessities

Humanized influenza monoclonal antibodies and methods of use thereof

#22 | 2021-07-22

US20210221906A1

Chemistry; metallurgy

Method of treating a tumor expressing carbonic anhydrase IX (G250) by administering a G250-specific chimeric antigen receptor

#23 | 2021-07-22

US20210221873A1

Chemistry; metallurgy

CONSERVED HEMAGGLUTININ EPITOPE, ANTIBODIES TO THE EPITOPE, AND METHODS OF USE

#24 | 2021-05-20

US20210147513A1

Chemistry; metallurgy

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

#25 | 2021-04-08

US20210101989A1

Chemistry; metallurgy

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

#26 | 2021-03-11

US20210070860A1

Chemistry; metallurgy

FC VARIANT COMPOSITIONS AND METHODS OF USE THEREOF

#27 | 2020-11-26

US20200369775A1

Chemistry; metallurgy

Methods for depleting or inhibiting the migration of regulatory T-cells in early or late stages of cancer

#28 | 2020-02-27

US20200062830A1

Chemistry; metallurgy

Flavivirus neutralizing antibodies and methods of use thereof

#29 | 2020-01-16

US20200017588A1

Chemistry; metallurgy

MODULAR TETRAVALENT BISPECIFIC ANTIBODY PLATFORM

#30 | 2019-09-12

US20190276544A1

Chemistry; metallurgy

AFFINITY MATURED ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE

#31 | 2019-09-12

US20190276523A1

Chemistry; metallurgy

Composition and methods of treating B cell disorders

#32 | 2019-09-12

US20190276519A1

Chemistry; metallurgy

Immunogenetic restriction on elicitation of antibodies

#33 | 2019-08-01

US20190233505A1

Chemistry; metallurgy

METHODS OF TREATING OR PREVENTING ZIKA VIRUS INFECTION

#34 | 2019-06-27

US20190194299A1

Chemistry; metallurgy

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

#35 | 2019-02-28

US20190062408A1

Chemistry; metallurgy

Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use

#36 | 2018-12-06

US20180346587A1

Chemistry; metallurgy

Human monoclonal anti-PD-L1 antibodies and methods of use

#37 | 2018-11-15

US20180327782A1

Chemistry; metallurgy

LENTIVIRAL VECTORS AND USES THEREOF

#38 | 2018-11-01

US20180312575A1

Chemistry; metallurgy

ANTIBODIES AGAINST INFLUENZA VIRUS AND METHODS OF USE THEREOF

#39 | 2018-09-20

US20180265587A1

Chemistry; metallurgy

Pharmaceutical compositions comprising humanized anti-CCR4 IgG4 antibody

#40 | 2018-09-06

US20180251531A1

Chemistry; metallurgy

Flavivirus neutralizing antibodies and methods of use thereof

#41 | 2018-04-12

US20180099040A1

Human necessities

Humanized influenza monoclonal antibodies and methods of use thereof

#42 | 2018-04-05

US20180094064A1

Chemistry; metallurgy

AFFINITY MATURED ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE

#43 | 2018-03-15

US20180072813A1

Chemistry; metallurgy

Carbonic anhydrase IX (G250) antibodies and methods of use thereof

#44 | 2018-02-01

US20180030147A1

Chemistry; metallurgy

Chimeric antigen receptors specific for carbonic acid anhydrase IX

#45 | 2017-12-21

US20170362297A1

Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

#46 | 2017-10-26

US20170304444A1

Human necessities

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

#47 | 2017-10-12

US20170290911A1

Human necessities

Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof

#48 | 2017-06-08

US20170158752A1

Chemistry; metallurgy

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

#49 | 2017-03-16

US20170073431A1

Chemistry; metallurgy

Humanized monoclonal antibodies and methods of use

#50 | 2016-06-30

US20160185865A1

Chemistry; metallurgy

Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use

#51 | 2016-01-28

US20160024189A1

Chemistry; metallurgy

Flavivirus neutralizing antibodies and methods of use thereof

#52 | 2015-10-01

US20150274835A1

Chemistry; metallurgy

Human monoclonal anti-PD-L1 antibodies and methods of use

#53 | 2015-04-30

US20150118153A1

Chemistry; metallurgy

Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use

#54 | 2014-01-09

US20140011982A1

Chemistry; metallurgy

Antibodies against influenza virus and methods of use thereof

#55 | 2013-12-19

US20130336923A1

Chemistry; metallurgy

Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody

#56 | 2013-09-19

US20130243749A1

Chemistry; metallurgy

Humanized monoclonal antibodies and methods of use

#57 | 2011-10-13

US20110250165A1

Chemistry; metallurgy

Antibodies against CXCR4 and methods of use thereof

#58 | 2011-02-17

US20110038935A1

Chemistry; metallurgy

ANTIBODIES AGAINST INFLUENZA VIRUS AND METHODS OF USE THEREOF

#59 | 2009-06-18

US20090155225A1

Chemistry; metallurgy

USES AND ISOLATION OF VERY SMALL OF EMBRYONIC-LIKE (VSEL) STEM CELLS

#60 | 2009-05-21

US20090130123A1

Chemistry; metallurgy

Antibodies to west nile virus polypeptides

#61 | 2009-03-12

US20090068095A1

Chemistry; metallurgy

Carbonic anhydrase IX (G250) anitbodies

#62 | 2008-02-14

US20080038231A1

Chemistry; metallurgy

PROCESSING PROCEDURE FOR PERIPHERAL BLOOD STEM CELLS

#63 | 2007-08-28

US9953344

Pseudotyped lentiviral vectors and uses thereof

#64 | 2007-03-06

US8822033

Nucleic acid delivery system, methods of synthesis and use thereof

#65 | 2006-02-16

US20060034834A1

Chemistry; metallurgy

Intrabody-mediated control of immune reactions

#66 | 2006-01-26

US20060019395A1

Chemistry; metallurgy

Lentiviral vectors and uses thereof

#67 | 2005-06-16

US20050129701A1

Chemistry; metallurgy

Antibody to latent membrane proteins and uses thereof

#68 | 2005-01-06

US20050003505A1

Chemistry; metallurgy

Pseudotyped lentiviral vectors and uses thereof

InventorID:

443594 ⎘